Scientists uncover potential treatment for painful side effect of diabetes

(Medical Xpress) -- Why diabetics suffer from increased pain and temperature sensitivity is a step closer to being understood and effectively treated.

Research published in the journal Nature Medicine reveals that a multi-national collaboration between scientists from Warwick Medical School in the UK, and universities in Germany, New York, Australia and Eastern Europe, has discovered key information around one of the most distressing side effects of diabetes.

Painful diabetic neuropathy (PDN), which is abnormal and experienced by roughly 50% of patients with diabetes, impairs patients' quality of life and affects sleep, mood, mobility, ability to work, relationships, self-esteem and independence.

Currently there is no clear understanding of how abnormal glucose metabolism produces heightened in diabetics, but this study offers vital new insights. The Warwick team of Dr Naila Rabbani and Professor Paul Thornalley have worked for 30 years on a reactive compound produced excessively from glucose in diabetes called methylglyoxal (MG). The new research led by Professors Angelika Bierhaus, Peter Nawroth and colleagues convincingly shows that MG is a new culprit in pain discomfort and, having pinpointed its relevance, further research is being undertaken to develop ways of inhibiting its activity and therefore reduce pain.

Professor Thornalley from the University of Warwick, explained: “MG appears to attack and modify a key protein in the nerve endings called ‘Nav 1.8’ causing nerves to become super-sensitive to pain and extremes of temperature. So diabetics typically develop a heightened sensitivity to hot and cold, accompanied with intense pain.

“This collaborative research indicates that using small peptides to ‘scavenge’ the problem-causing compound will lead to a reduction in pain and opens up new routes to develop accurate, targeted drug treatments to help diabetics.”

He added that an additional research programme at Warwick is currently investigating ways to increase the amount of an enzyme, glyoxalase 1 (Glo1), which removes MG catalytically.

“With global rates of diabetes increasing each year, our research is offering valuable insight into the science behind why causes so many side effects and ultimately how we can develop treatments to improve patient care and outcomes.”

More information: DOI:10.1038/nm.2750

Related Stories

Diabetics urged to steer clear of high fat diet

Mar 27, 2012

(Medical Xpress) -- The current thinking around following a high fat, low carb diet to encourage weight loss in diabetics with Type 2 Diabetes, may be misguided say researchers from Warwick Medical School.

New insight into pain mechanisms

Apr 25, 2012

(Medical Xpress) -- Researchers in the UCL Wolfson Institute for Biomedical Research have made a discovery which could help the development of analgesic drugs able to treat nerve damage-related pain.

Chronic pain gene identified

Sep 08, 2011

British researchers say they have identified the gene that controls chronic pain, opening the door to new drug therapies that block the chemical processes that cause chronic back pain, headaches or arthritis.

Recommended for you

Magnesium cuts diabetes risk

Oct 20, 2014

Getting enough magnesium in the diet may reduce the risk of diabetes, especially for those who already show signs of heading that way.

User comments